176 related articles for article (PubMed ID: 26740287)
1. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
Bagazgoitia L; Cuevas J; Juarranz A
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
[TBL] [Abstract][Full Text] [Related]
3. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
Oh CW; Penneys N
Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
[TBL] [Abstract][Full Text] [Related]
4. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
[TBL] [Abstract][Full Text] [Related]
5. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions.
Abbas O; Richards JE; Yaar R; Mahalingam M
Mod Pathol; 2011 Jan; 24(1):90-7. PubMed ID: 20852595
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
10. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
13. Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its association with human papillomavirus infection.
Wu YH; Hsiao PF; Chen CK
Am J Dermatopathol; 2015 Jun; 37(6):462-8. PubMed ID: 25747812
[TBL] [Abstract][Full Text] [Related]
14. Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate.
Mohanna MT; Hofbauer GF
Dermatology; 2016; 232 Suppl 1():14-6. PubMed ID: 27513957
[TBL] [Abstract][Full Text] [Related]
15. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.
Wu Y; Liu H; Li J
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):206-8. PubMed ID: 17497299
[TBL] [Abstract][Full Text] [Related]
16. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
18. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
19. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
20. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.
Muehleisen B; Schaerer L; Dummer R; Burg G; Hofbauer GF
J Cutan Pathol; 2007 Jan; 34(1):1-6. PubMed ID: 17214847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]